Given that BCL2 is known to safeguard thyroid carcinomas against apoptosis induced by chemotherapy [22], the SS-BCL2-TC pathway could represent a detrimental effect of SS on the treatment of TC. The gene discussed is BCL2; the disease is thyroid gland carcinoma.